These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 35392870)

  • 1. Clustering of lung diseases in the family of interstitial lung disease patients.
    Terwiel M; Grutters JC; van Moorsel CHM
    BMC Pulm Med; 2022 Apr; 22(1):134. PubMed ID: 35392870
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Family History of Pulmonary Fibrosis Predicts Worse Survival in Patients With Interstitial Lung Disease.
    Cutting CC; Bowman WS; Dao N; Pugashetti JV; Garcia CK; Oldham JM; Newton CA
    Chest; 2021 May; 159(5):1913-1921. PubMed ID: 33484728
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Smoking-related emphysema is associated with idiopathic pulmonary fibrosis and rheumatoid lung.
    Antoniou KM; Walsh SL; Hansell DM; Rubens MR; Marten K; Tennant R; Hansel T; Desai SR; Siafakas NM; du Bois RM; Wells AU
    Respirology; 2013 Nov; 18(8):1191-6. PubMed ID: 23819865
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Baseline characteristics and comorbidities in the CAnadian REgistry for Pulmonary Fibrosis.
    Fisher JH; Kolb M; Algamdi M; Morisset J; Johannson KA; Shapera S; Wilcox P; To T; Sadatsafavi M; Manganas H; Khalil N; Hambly N; Halayko AJ; Gershon AS; Fell CD; Cox G; Ryerson CJ
    BMC Pulm Med; 2019 Nov; 19(1):223. PubMed ID: 31771541
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Healthcare Resources Utilization and Costs of Patients with Non-IPF Progressive Fibrosing Interstitial Lung Disease Based on Insurance Claims in the USA.
    Olson AL; Maher TM; Acciai V; Mounir B; Quaresma M; Zouad-Lejour L; Wells CD; De Loureiro L
    Adv Ther; 2020 Jul; 37(7):3292-3298. PubMed ID: 32451950
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interstitial Lung Disease in Relatives of Patients with Pulmonary Fibrosis.
    Hunninghake GM; Quesada-Arias LD; Carmichael NE; Martinez Manzano JM; Poli De Frías S; Baumgartner MA; DiGianni L; Gampala-Sagar SN; Leone DA; Gulati S; El-Chemaly S; Goldberg HJ; Putman RK; Hatabu H; Raby BA; Rosas IO
    Am J Respir Crit Care Med; 2020 May; 201(10):1240-1248. PubMed ID: 32011908
    [No Abstract]   [Full Text] [Related]  

  • 7. A cluster-based analysis evaluating the impact of comorbidities in fibrotic interstitial lung disease.
    Wong AW; Lee TY; Johannson KA; Assayag D; Morisset J; Fell CD; Fisher JH; Shapera S; Gershon AS; Cox G; Halayko AJ; Hambly N; Manganas H; Sadatsafavi M; Wilcox PG; To T; Marcoux V; Khalil N; Kolb M; Ryerson CJ
    Respir Res; 2020 Dec; 21(1):322. PubMed ID: 33287805
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nintedanib in patients with progressive fibrosing interstitial lung diseases-subgroup analyses by interstitial lung disease diagnosis in the INBUILD trial: a randomised, double-blind, placebo-controlled, parallel-group trial.
    Wells AU; Flaherty KR; Brown KK; Inoue Y; Devaraj A; Richeldi L; Moua T; Crestani B; Wuyts WA; Stowasser S; Quaresma M; Goeldner RG; Schlenker-Herceg R; Kolb M;
    Lancet Respir Med; 2020 May; 8(5):453-460. PubMed ID: 32145830
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence and Incidence of Chronic Fibrosing Interstitial Lung Diseases with a Progressive Phenotype in the United States Estimated in a Large Claims Database Analysis.
    Olson AL; Patnaik P; Hartmann N; Bohn RL; Garry EM; Wallace L
    Adv Ther; 2021 Jul; 38(7):4100-4114. PubMed ID: 34156606
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A cohort study of Danish patients with interstitial lung diseases: burden, severity, treatment and survival.
    Hyldgaard C
    Dan Med J; 2015 Apr; 62(4):B5069. PubMed ID: 25872544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design and baseline characteristics of the ILD-PRO registry in patients with progressive pulmonary fibrosis.
    Lobo LJ; Liu Y; Li P; Ramaswamy M; Swaminathan AC; Veeraraghavan S; Fan Y; Neely ML; Palmer SM; Olson AL;
    BMC Pulm Med; 2024 Sep; 24(1):468. PubMed ID: 39334205
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence and prognosis of unclassifiable interstitial lung disease.
    Ryerson CJ; Urbania TH; Richeldi L; Mooney JJ; Lee JS; Jones KD; Elicker BM; Koth LL; King TE; Wolters PJ; Collard HR
    Eur Respir J; 2013 Sep; 42(3):750-7. PubMed ID: 23222877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characteristics and outcomes of patients hospitalized with interstitial lung diseases in Spain, 2014 to 2015.
    Pedraza-Serrano F; Jiménez-García R; López-de-Andrés A; Hernández-Barrera V; Sánchez-Muñoz G; Puente-Maestu L; de-Miguel-Díez J
    Medicine (Baltimore); 2019 May; 98(21):e15779. PubMed ID: 31124970
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interstitial lung abnormalities and interstitial lung diseases associated with cigarette smoking in a rural cohort undergoing surgical resection.
    Sangani RG; Deepak V; Ghio AJ; Forte MJ; Zulfikar R; Patel Z; King A; Alshaikhnassir E; Abbas G; Vos J
    BMC Pulm Med; 2022 Apr; 22(1):172. PubMed ID: 35488260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Health care costs and utilization of progressive fibrosing lung disease by underlying interstitial lung disease type.
    Nili M; Steffens A; Anderson A; Brekke L; Grace Johnson M; Veeranki P; Olson AL
    J Manag Care Spec Pharm; 2024 Feb; 30(2):163-174. PubMed ID: 38308627
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of Gender on the Characteristics of Patients with Idiopathic Pulmonary Fibrosis Included in the RaDiCo-ILD Cohort.
    Cottin V; Gueguen S; Jouneau S; Nunes H; Crestani B; Bonniaud P; Wémeau-Stervinou L; Reynaud-Gaubert M; Israël-Biet D; Cadranel J; Marchand-Adam S; Quétant S; Hirschi S; Montani D; Gamez AS; Chevereau M; Dufaure-Garé I; Amselem S; Clement A;
    Respiration; 2022; 101(1):34-45. PubMed ID: 34515219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tobacco smoking is associated with combined pulmonary fibrosis and emphysema and worse outcomes in interstitial lung disease.
    Douglas D; Keating L; Strykowski R; Lee CT; Garcia N; Selvan K; Kaushik N; Bauer Ventura I; Jablonski R; Vij R; Chung JH; Bellam S; Strek ME; Adegunsoye A
    Am J Physiol Lung Cell Mol Physiol; 2023 Aug; 325(2):L233-L243. PubMed ID: 37366539
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advances with pharmacotherapy for the treatment of interstitial lung disease.
    Comes A; Sgalla G; Perrotta A; Richeldi L
    Expert Opin Pharmacother; 2022 Mar; 23(4):483-495. PubMed ID: 34907821
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characteristics of lung cancer among patients with idiopathic pulmonary fibrosis and interstitial lung disease - analysis of institutional and population data.
    Yoon JH; Nouraie M; Chen X; Zou RH; Sellares J; Veraldi KL; Chiarchiaro J; Lindell K; Wilson DO; Kaminski N; Burns T; Trejo Bittar H; Yousem S; Gibson K; Kass DJ
    Respir Res; 2018 Oct; 19(1):195. PubMed ID: 30285867
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Likelihood of pulmonary hypertension in patients with idiopathic pulmonary fibrosis and emphysema.
    Jacob J; Bartholmai BJ; Rajagopalan S; Karwoski R; Nair A; Walsh SLF; Barnett J; Cross G; Judge EP; Kokosi M; Renzoni E; Maher TM; Wells AU
    Respirology; 2018 Jun; 23(6):593-599. PubMed ID: 29237236
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.